Experimental therapeutic cancer vaccine leads to significant tumor regression in mice

Close Up Scientist using microscope in laboratory room while making medical testing and research

An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, report investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

$3.2 million grant helps to study the benefits of mind-body practices for patients undergoing surgery

Previous article

New study illuminates why cancers caused by BRCA mutations recur

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News